Blue Water Biotech, Inc. Common Stock

BWV: Blue Water Biotech Inc is a biotechnology company focused on developing transformational therapies to address health challenges globally. Blue Water is developing a Streptococcus pneumoniae vaccine candidate, designed to specifically prevent infectious middle ear infections, known as acute otitis media (AOM), in children, and prevention of pneumonia in the elderly. The Company is also developing a universal flu vaccine that will protect from all virulent strains in addition to licensing a novel norovirus (NoV) S&P nanoparticle versatile virus-like particle (VLP) vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, among others.